- Featured Product
- KD/KO Validated
SETD8 Polyklonaler Antikörper
SETD8 Polyklonal Antikörper für WB, IHC, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus
Anwendung
WB, IHC, Indirect ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 14063-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
14063-1-PBS bindet in WB, IHC, Indirect ELISA SETD8 und zeigt Reaktivität mit human, Maus
| Getestete Reaktivität | human, Maus |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Polyklonal |
| Typ | Antikörper |
| Immunogen | SETD8 fusion protein Ag5114 |
| Vollständiger Name | SET domain containing (lysine methyltransferase) 8 |
| Berechnetes Molekulargewicht | 43 kDa |
| Beobachtetes Molekulargewicht | 43 kDa |
| GenBank-Zugangsnummer | BC050346 |
| Gene symbol | SETD8 |
| Gene ID (NCBI) | 387893 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Antigen-Affinitätsreinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
SETD8, also known as Set8, PR-Set7, or KMT5A, is a member of the SET domain family of histone lysine methyltransferases and, to date, the only known enzyme that catalyzes monomethylation of H4K20 in eukaryotes, which is involved in DNA damage response, mitotic condensation, and DNA replication. SETD8 is overexpressed in various types of tumors, such as bladder cancer, non-small cell lung carcinoma, and small cell lung carcinoma, and is associated with a shorter survival time for gastric, esophageal, and prostate cancer patients.









